Skip to main content

Month: April 2023

NXT Energy Solutions Announces 2022 Year-End Results

CALGARY, Alberta, March 31, 2023 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) today announced the Company’s financial and operating results for the quarter and year ended December 31, 2022 as well as significant subsequent events. All dollar amounts herein are in Canadian Dollars unless otherwise identified. Financial and Operating Highlights Key financial and operational highlights are summarized below:January 25, 2023, the Company closed a Private Placement by issuing 8,510,000 common shares, at $0.195 per common shares, for aggregate gross proceeds of approximately $1,659,450, less issuance costs of $1,170; During December 2022 a rights offering and the first tranche of the private placement contributed $0.43 million of cash; In January, the Board...

Continue reading

Red Pine Announces Upsize of Previously Announced Private Placement to C$6.8 Million

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO, March 31, 2023 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company“) is pleased to announce that it has entered into an amendment agreement with Haywood Securities Inc. (“Haywood”), as co-lead agent and sole bookrunner, on behalf of 3L Capital Inc. (“3L Capital” and together with Haywood, the “Co-Lead Agents”), as co-lead agent, and a syndicate of agents (together with the Co-Lead Agents, the “Agents”) in connection with a private placement on a “best efforts” agency basis, to increase the size of the previously announced private placement to gross proceeds of up to $6,800,000 (the “Upsized Offering”). The Upsized Offering will consist of any combination...

Continue reading

Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement

TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and internationally. The business combination with Deep Medicine Acquisition Corp. values TruGolf’s at an implied enterprise value of $125 million, including certain payments contingent on future milestones.● The public listing enables TruGolf to accelerate its software development, golf simulator manufacturing and sales, as well as finalize new-generation hardware and software technology that aim to revolutionize the virtual golf experience.   ● The proceeds from the transaction will enhance TruGolf’s production capacity, new product research and development, working capital and expansion.   ● Mr. Christopher Jones, CEO and Chairman of...

Continue reading

Sabina Gold & Silver Announces Financial Results for the Year Ended December 31, 2022

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (“Sabina”) or (the “Company”) (SBB – TSX) reports the financial results for the year ended December 31, 2022. “2022 was a year of continued de-risking at Back River,” said Bruce McLeod, the Company’s President & CEO. “With the completion of our project financing package and related equity financings, we were able to advance the Goose Mine to a formal construction decision. All work since then has been focused on executing and delivering a successful build for first gold in Q1, 2025. Subsequent to the year end, Sabina received a proposal from B2Gold Corp. to purchase all the issued and outstanding shares in the Company in an all-share transaction. After careful consideration, the Board and management of the Company determined that...

Continue reading

AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering

New York, NY, March 31, 2023 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (the “Company”) (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares (“ADSs”), pre-funded warrants to purchase ADSs and warrants to purchase ADSs in a registered direct offering.  The Company plans to use the net proceeds from the offering for the advancement of our research and development activities, working capital and general corporate purposes. Under the terms of the securities...

Continue reading

Global Tech Industries Group, Inc. extends closing date with Wildfire Media Corp and the 1-800-LAW-FIRM brand to May 15, 2023

New York, NY, March 31, 2023 (GLOBE NEWSWIRE) — (GTII: OTCQB) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that it has signed a third extension agreement with Wildfire Media Corp, (“Wildfire”), extending the original agreement to May 15, 2023, in order to allow Wildfire more time to complete the two-year PCAOB audit undertaken by UHY, LLP, an auditing firm based in Sterling Heights, MI. The two-year audit is a requirement in order to complete and close the acquisition of Wildfire and the 1-800-LAWFIRM brand by GTII. About GTII: GTII is a publicly traded Company incorporated in the state of Nevada, specializing in the pursuit of acquiring new and innovative technologies. Visit GTII here https://gtii-us.com/ Please follow our Company at: www.otcmarkets.com/stock/GTII About Wildfire...

Continue reading

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

InterCure 2020-2022 Financials InterCure 2020-2022 FinancialsRecord fiscal year 2022 revenue of $150 million Record fiscal year 2022 Adjusted EBITDA* of $32 million Record fiscal year 2022 net income of $17 million Generated $20 Million cash flow from operations Strong balance sheet with over $95 million cash NEW YORK, TORONTO, and HERZLIYA, Israel, March 31, 2023 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.Full Year 2022 Key Financial & Operating Highlights (Cannabis Sector)Record fiscal year 2022 revenue of $150 million...

Continue reading

Mydecine Reports Financial Results for the Year Ended December 2022

DENVER, March 31, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported company highlights and financial results for the years ended December 31, 2022 and 2021. Company Highlights In 2022, Mydecine continued to define its focus and clinical trial execution strategy. The Company reached several milestones with the goal to become an efficiently operated biotechnology company. Of significant note, Mydecine announced several advancements in drug development including first and second-generation drug candidates. We have identified and pursued the indications that management believes will be most promising from the view of treating global...

Continue reading

IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update

Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its financial results for the year ended December 31, 2022. Financial Highlights from FY 2022 (all comparisons are with IMAC for the year ended December 31 unless otherwise indicated):Annual revenue was $16.1 million, up 14.3% from $14.1 million in 2021 Patient revenue increased to $105 per visit compared to $84 per visit in 2021Corporate Highlights in Q4 2022 and Year To Date 2023:Completed the sale of The BackSpace to Curis Functional Health. Completed the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.